Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,689 | 249 | 97.8% |
| Education | $103.29 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,267 | 80 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $485.24 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $479.72 | 20 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $278.43 | 13 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $251.66 | 13 | $0 (2024) |
| Lilly USA, LLC | $245.20 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $242.31 | 13 | $0 (2024) |
| Gilead Sciences, Inc. | $179.83 | 5 | $0 (2019) |
| Merck Sharp & Dohme LLC | $159.74 | 10 | $0 (2022) |
| Celgene Corporation | $147.56 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $991.50 | 47 | ABBVIE INC. ($344.07) |
| 2023 | $752.69 | 35 | ABBVIE INC. ($137.45) |
| 2022 | $359.70 | 18 | ABBVIE INC. ($135.63) |
| 2021 | $134.55 | 5 | Janssen Biotech, Inc. ($134.55) |
| 2020 | $127.35 | 8 | AbbVie Inc. ($29.67) |
| 2019 | $957.40 | 55 | AbbVie, Inc. ($251.92) |
| 2018 | $771.91 | 50 | AbbVie, Inc. ($264.77) |
| 2017 | $697.48 | 33 | Valeant Pharmaceuticals North America LLC ($278.43) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: GI COLON PREP | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/23/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/13/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Immunology | ||||||
| 09/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: VIROLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/01/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: VIROLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 435 | 2,698 | $502,672 | $110,689 |
| 2022 | 10 | 386 | 399 | $236,300 | $45,757 |
| 2021 | 10 | 609 | 622 | $261,975 | $54,992 |
| 2020 | 10 | 473 | 490 | $176,515 | $41,420 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 15 | 2,240 | $234,192 | $58,185 | 24.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 79 | 79 | $70,310 | $15,790 | 22.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 96 | 97 | $76,630 | $12,350 | 16.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 93 | 97 | $58,200 | $7,874 | 13.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 16 | 35 | $12,950 | $3,702 | 28.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 21 | 21 | $13,965 | $3,401 | 24.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 23 | 24 | $15,000 | $2,781 | 18.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $8,645 | $2,323 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 26 | $5,850 | $2,283 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,080 | $1,342 | 32.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 13 | 24 | $2,400 | $544.08 | 22.7% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 30 | 30 | $450.00 | $115.50 | 25.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 92 | 93 | $82,770 | $18,558 | 22.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 74 | 74 | $58,460 | $8,023 | 13.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 83 | 85 | $51,000 | $7,099 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 34 | $7,650 | $2,992 | 39.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 15 | 15 | $9,975 | $2,724 | 27.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 14 | 14 | $9,310 | $2,545 | 27.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 12 | 14 | $5,180 | $1,557 | 30.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 15 | 15 | $9,375 | $1,533 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 13 | $1,950 | $566.34 | 29.0% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 39 | 42 | $630.00 | $159.72 | 25.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 90 | 90 | $80,100 | $18,032 | 22.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 116 | 116 | $91,640 | $14,225 | 15.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 83 | 84 | $50,400 | $5,607 | 11.1% |
About Dr. Scott Mcshane, DO
Dr. Scott Mcshane, DO is a Internal Medicine healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1629330394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Mcshane, DO has received a total of $4,793 in payments from pharmaceutical and medical device companies, with $991.50 received in 2024. These payments were reported across 251 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,689).
As a Medicare-enrolled provider, Mcshane has provided services to 1,903 Medicare beneficiaries, totaling 4,209 services with total Medicare billing of $252,858. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Spokane, WA
- Active Since 06/08/2012
- Last Updated 08/14/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629330394
Products in Payments
- STELARA (Biological) $530.19
- XIFAXAN (Drug) $453.34
- Humira (Biological) $407.27
- DUPIXENT (Biological) $333.88
- RINVOQ (Biological) $192.13
- OMVOH (Drug) $162.26
- ENTYVIO (Biological) $161.89
- MAVYRET (Drug) $159.59
- ZEPOSIA (Drug) $147.56
- Cimzia (Drug) $129.85
- SKYRIZI (Biological) $124.95
- Epclusa (Drug) $106.67
- DIFICID (Drug) $95.00
- Mavyret (Drug) $94.15
- XIFAXANIBSD (Drug) $90.05
- Creon (Drug) $87.84
- Entyvio (Biological) $80.42
- UCERIS (Drug) $79.27
- CREON (Drug) $67.78
- UCERIS TABLETS (Drug) $67.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Spokane
Katherine Tuttle, Md, MD
Internal Medicine — Payments: $450,232
Jessica Craddock, Md, MD
Internal Medicine — Payments: $344,643
Dr. Radica Alicic, M.d, M.D
Internal Medicine — Payments: $50,393
James Mudd, M.d, M.D
Internal Medicine — Payments: $30,546
Dr. Rachel Safran, M.d, M.D
Internal Medicine — Payments: $17,911
Dr. Usman Ajaz, M.d, M.D
Internal Medicine — Payments: $9,648